Corporate dispute at B3: Arbitration halts R$ 6 billion Oncoclínicas offer

The corporate dispute involving the Josephina 3 fund and asset manager Latache at the B3 arbitration chamber places under scrutiny a capital transaction exceeding the significant mark of R$ 6 billion, demonstrating that the appetite for restructuring in the healthcare sector clashes with the rigidity of governance agreements. This legal-financial clash occurs in an environment where the exchange rate remains anchored around R$ 5.16 per dollar, recording a 30-day variation of -0.46%, which theoretically favors foreign capital flow, yet runs into internal allocation and corporate control conflicts. Cross-referencing this scenario with the recent history of corporate instability and risk management failures highlights that the Brazilian market demands a high premium for contractual uncertainty. Inflation measured by the 12-month accumulated IPCA at 4.44%, with a 30-day monthly variation of -4.31%, corroborates a price stabilization scenario that should facilitate fundraising, but distrust regarding minority protection curbs institutional investor momentum. Over the next 30 to 90 days, the trend points to an increase in the judicialization of large-scale corporate operations, with the commercial dollar operating stable at R$ 5.1625, keeping external appetite latent while containing large M&A movements. Analysts note that the Selic rate at 14.00% per year forces shareholders to demand much higher operational returns to justify the risks inherent in public offers contested in arbitration. For the 180-day horizon, the outcome of this arbitration will serve as a definitive barometer for minority shareholder protection on the B3, testing private dispute resolution mechanisms.